| Literature DB >> 31797925 |
Xin Luo1,2,3, Yaoxi He1,2,3, Chao Zhang4, Xiechao He1,3, Lanzhen Yan3,5, Min Li1,2, Ting Hu1,2, Yan Hu1,2, Jin Jiang1,2, Xiaoyu Meng1,2, Weizhi Ji6, Xudong Zhao3,5, Ping Zheng7,8, Shuhua Xu9,10,11,12, Bing Su13,14,15.
Abstract
CRISPR-Cas9 is a widely-used genome editing tool, but its off-target effect and on-target complex mutations remain a concern, especially in view of future clinical applications. Non-human primates (NHPs) share close genetic and physiological similarities with humans, making them an ideal preclinical model for developing Cas9-based therapies. However, to our knowledge no comprehensive in vivo off-target and on-target assessment has been conducted in NHPs. Here, we perform whole genome trio sequencing of Cas9-treated rhesus monkeys. We only find a small number of de novo mutations that can be explained by expected spontaneous mutations, and no unexpected off-target mutations (OTMs) were detected. Furthermore, the long-read sequencing data does not detect large structural variants in the target region.Entities:
Mesh:
Year: 2019 PMID: 31797925 PMCID: PMC6892871 DOI: 10.1038/s41467-019-13481-y
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919
Fig. 1Detecting de novo mutations (DNMs) in the Cas9-treated monkeys. a The analyzed trios of rhesus monkeys (rm) and cynomolgus monkey (cm). F father, M mother, O offspring, ko knockout, ki knockin, B brain, L liver, and M muscle. b The pipeline of variant calling, filtering, and DNMs identification. HC.DNM-high confident DNMs. c Venn diagram of the high-confident DNMs for rmO2-B identified by overlapping candidate DNMs from four different calling tools. d Summary of the identified high-confident DNMs. The circles refer to Ca9-treated rhesus monkeys and the triangle refers to the Ca9-treated cynomolgus monkey. The green shadow indicates the range of expected DNMs (22–78) per generation given the known spontaneous mutation rates of primates.
Summary of trio WGS and identification of DNMs.
| Monkey ID | Relationship | Treatment group | Depth | On-target ratio | Candidate DNMs | Final SNVs | Final INDELs |
|---|---|---|---|---|---|---|---|
| rmF | Father | Wildtype | 45.81 | – | – | – | |
| rmM1 | Mother-1 | Wildtype | 46.23 | – | – | – | |
| rmM2 | Mother-2 | Wildtype | 45.23 | – | – | – | |
| rmO1 | Offspring-1 | Cas9-treat | 48.39 | 0.435 | 1324 | 34 | 5 |
| rmO2-B | Offspring-2-brain | Cas9-treat | 45.98 | 0.953 | 1169 | 29 | 3 |
| rmO2-M | Offspring-2-muscle | Cas9-treat | 44.85 | 0.938 | 1188 | 30 | 3 |
| rmO2-L | Offspring-2-liver | Cas9-treat | 45.35 | 0.952 | 1,230 | 29 | 2 |
| rmO3 | Offspring-3 | Cas9-treat | 46.84 | 0.122 | 1267 | 38 | 1 |
| rmO4 | Offspring-4 | Cas9-treat | 45.92 | 0 | 1531 | 30 | 1 |
| rmO5 | Offspring-5 | Cas9-treat | 47.60 | 0.321 | 1847 | 37 | 1 |
| cmF | Father | Wildtype | 64.08 | – | – | – | |
| cmM | Mother | Wildtype | 76.11 | – | – | – | |
| cmO | Offspring | Cas9-treat | 68.42 | – | 6060 | 32 | 3 |
Fig. 2Long-read sequencing analysis of the sgRNA targeted regions. a The two sgRNA target regions of MCPH1 (exon2 and exon4, respectively) tested by long-range PCR and PacBio sequencing. The upper and bottom panels show the coverage of the PacBio reads on the target regions based on whole-region view and cut-site region view, respectively. The cut sites of the sgRNAs in exon2 and exon4 are indicated with red arrow, red line, and shadow frame in red. b A ~300 bp insertion at the near-target region (2.3 kb from the cut-site) in two Cas9-edited monkeys (rmO1 and rmO4), which inherited from their wildtype mother (rmM1 and rmM2).